ARCHIVES

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

This article is from The Cancer Letter archive.

Vol. 39 No. 45 | December 17, 2013

Download PDF Visit The Full Archive

Related Articles

NIH Probing: Double Dipping” Allegation

September 4, 1981

UC Breast Cancer ProgramTo Award $20 Million In Grants

December 16, 1994

Buenos Aires Academy Denies Argentina Prosecutes Scientist

July 28, 1978

USPSTF Delivers “D” Recommendation For Ovarian Cancer Screening

September 28, 2012

Legal experts say too many conflicts involved. HHS gave von Eschenbach a waiver for his role in C-Change.

September 30, 2005

NCAB Accepts Plan for Organ Systems Program, Remains Split On Some Issues

February 11, 1983